{
    "patient": {
        "Name": "Mark Abbott",
        "DateOfBirth": "1981-01-13",
        "Sex": "Female",
        "Diagnosis": "Small cell carcinoma",
        "BodyPart": "Prostate",
        "Physician": "Dr. Bradley Huang",
        "TreatingInstitution": "Chandler-Hernandez"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Prostate",
            "CollectedDate": "2023-09-14",
            "ReceivedDate": "2023-09-18",
            "TumorPercentage": "42%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-09-17",
            "ReceivedDate": "2023-09-22"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "IKZF1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.N159Y Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "39.35%"
            },
            {
                "Gene": "HBB",
                "DNA Alteration": "c.79G>A",
                "GeneMutation": "p.E7K Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "14.8%"
            },
            {
                "Gene": "XPC",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.S346P Frameshift-LOF",
                "VariantAlleleFraction": "28.56%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "PTEN",
                "DNA Alteration": "c.545T>A",
                "GeneMutation": "p.R130Q Nonsense-GOF",
                "VariantAlleleFraction": "7.51%"
            },
            {
                "Gene": "NCSTN",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.R130L Spliceregionvariant-GOF",
                "VariantAlleleFraction": "2.35%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "CDC73"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "28 m/Mb",
            "Tmbpercentile": "82%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "High"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}